Cloudbreak Pharma Inc.

Cloudbreak Pharma Inc.

2592.HK
Cloudbreak Pharma Inc.HK flagHong Kong Stock Exchange
1.29
HKD
-0.14
- -
1.11BMarket Cap

Income Statement (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
10
- -
+ Sales & Services Revenue
- -
- -
10
- -
- Cost of Revenue
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
+ Other Operating Income
- -
- -
-10
- -
- Operating Expenses
24
36
47
107
+ Selling, General & Admin
5
3
9
41
+ Research & Development
15
27
38
67
+ Other Operating Expense
3
6
- -
- -
Operating Income (Loss)
-24
-36
-37
-107
- Non-Operating (Income) Loss
43
94
61
-40
+ Interest Expense, Net
-2
-4
-2
-1
+ Interest Expense
- -
- -
- -
- -
- Interest Income
2
4
2
1
+ Other Non-Op (Income) Loss
45
97
63
-39
Pretax Income
-67
-129
-98
-68
- Income Tax Expense (Benefit)
- -
- -
1
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
Income (Loss) from Cont Ops
-67
-129
-99
-68
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
Income (Loss) Incl. MI
-67
-129
-99
-68
- Minority Interest
- -
- -
- -
- -
Net Income, GAAP
-67
-129
-99
-68
- Preferred Dividends
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-67
-129
-99
-68
EBIT
-24
-36
-37
-107
EBITDA
-24
-36
-37
-107
EBITDA Margin (%)
- -
- -
-372.21
- -
EBITA
-24
-37
-38
-108
Gross Margin (%)
- -
- -
100
- -
Operating Margin (%)
- -
- -
-372.21
- -
Profit Margin (%)
- -
- -
-991.3
- -
Sales per Employee
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
Depreciation Expense
- -
1
1
1
Basic Weighted Avg Shares
839
839
475
- -
Basic EPS, GAAP
-0.08
-0.15
-0.21
- -
Basic EPS from Cont Ops
-0.08
-0.15
-0.21
- -
Diluted Weighted Avg Shares
839
839
839
- -
Diluted EPS, GAAP
-0.08
-0.15
-0.12
- -
Diluted EPS from Cont Ops
-0.08
-0.15
-0.12
- -

Balance Sheet (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
Total Current Assets
80
61
38
64
+ Cash, Cash Equivalents & STI
79
60
35
58
+ Cash & Cash Equivalents
16
53
35
40
+ ST Investments
63
8
- -
18
+ Accounts & Notes Receiv
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
+ Other ST Assets
1
1
3
6
+ Misc ST Assets
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
Total Noncurrent Assets
2
3
2
2
+ Property, Plant & Equip, Net
2
2
1
1
+ Property, Plant & Equip
2
2
2
2
- Accumulated Depreciation
- -
1
1
2
+ LT Investments & Receivables
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
+ Other LT Assets
- -
2
2
2
+ Total Intangible Assets
- -
2
2
2
+ Goodwill
- -
- -
- -
- -
+ Other Intangible Assets
- -
2
2
2
+ LT Deferred Tax Assets
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
Total Assets
82
65
40
67
+ Payables & Accruals
- -
- -
- -
- -
+ Accounts Payable
1
2
2
1
+ Accrued Taxes
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
+ Other Payables & Accruals
-1
-2
-2
-1
+ ST Debt
- -
- -
- -
1
+ ST Borrowings
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
+ Other ST Liabilities
226
327
391
5
+ Deferred Revenue
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Misc ST Liabilities
226
327
391
5
Total Current Liabilities
227
327
391
6
+ LT Debt
1
- -
- -
- -
+ LT Borrowings
- -
- -
- -
- -
+ LT Finance Leases
1
- -
- -
- -
+ Other LT Liabilities
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
+ Misc LT Liabilities
- -
- -
- -
- -
Total Noncurrent Liabilities
1
- -
- -
- -
Total Liabilities
227
328
392
6
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
+ Share Capital & APIC
258
258
258
686
+ Common Stock
- -
- -
- -
- -
+ Additional Paid in Capital
258
258
258
686
- Treasury Stock
- -
- -
- -
- -
+ Retained Earnings
-116
-245
-344
-412
+ Other Equity
- -
- -
- -
- -
Equity Before Minority Interest
-145
-263
-352
60
+ Minority/Non Controlling Interest
- -
- -
- -
- -
Total Equity
-145
-263
-352
60
Total Liabilities & Equity
82
65
40
67
Shares Outstanding
839
839
839
845
Number of Employees
- -
- -
- -
- -
Capital Leases - Total
1
1
1
- -
Net Debt
-16
-53
-35
-40
Net Debt to Equity
10.96
20.04
9.92
-65.64
Tangible Common Equity Ratio
-176.84
-418.6
-918.3
90.59
Current Ratio
0.35
0.19
0.1
10.68
Cash Conversion Cycle
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2022 Y
2023 Y
2024 Y
2025 Y
As of date
12/31/2022
12/31/2023
12/31/2024
12/31/2025
+ Net Income
-67
-129
-98
-68
+ Depreciation & Amortization
- -
- -
- -
- -
+ Non-Cash Items
45
106
73
19
+ Stock-Based Compensation
1
14
11
58
+ Deferred Income Taxes
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
+ Other Non-Cash Adj
43
92
61
-39
+ Chg in Non-Cash Work Cap
2
1
-1
-3
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
- -
-1
-3
+ Inc (Dec) in Accts Payable
- -
- -
- -
- -
+ Inc (Dec) in Other
2
1
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Operating Activities
-20
-23
-27
-52
+ Change in Fixed & Intang
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
+ Acq of Fixed & Intang
-1
-2
- -
-18
+ Acq of Fixed Prod Assets
-1
-1
- -
- -
+ Acq of Intangible Assets
- -
-2
- -
-18
+ Cash (Repurchase) of Equity
16
- -
- -
78
+ Increase in Capital Stock
16
- -
- -
78
+ Decrease in Capital Stock
- -
- -
- -
- -
+ Net Change in LT Investment
-31
56
8
- -
+ Dec in LT Investment
296
130
8
- -
+ Inc in LT Investment
-327
-75
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
+ Other Investing Activities
2
4
2
1
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Investing Activities
-30
57
9
-17
+ Dividends Paid
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
+ Cash From Debt
- -
285
14
- -
+ Repayments of Debt
- -
-285
-14
- -
+ Other Financing Activities
-30
2
- -
-5
+ Net Cash From Disc Ops
- -
- -
- -
- -
Cash from Financing Activities
-14
2
- -
74
Effect of Foreign Exchange Rates
- -
- -
- -
- -
Net Changes in Cash
-64
37
-18
5
EBITDA
-24
-36
-37
-107
EBITDA Margin (%)
- -
- -
-372.21
- -
Free Cash Flow
-21
-25
-27
-70
Net Cash Paid for Acquisitions
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-23
-27
-51
Free Cash Flow per Basic Share
-0.02
-0.03
-0.06
- -
Price/Free Cash Flow
- -
- -
- -
- -
Cash Flow to Net Income
0.3
0.17
0.27
0.76
Capital Expenditures
-1
-2
- -
-18